A prospective study of neuropsychological functioning in testicular cancer patients

Annals of Oncology

Volumn 22, Issue 5, 2011, Pages 1062-1070

  Skaali, T ^a   Fossa S D ^a   Andersson, S ^a   Cvancarova, M ^a   Langberg, C W ^b   Lehne, G ^a   Dahl, A A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemotherapy; Cognitive function; Neuropsychological functioning; Neurotoxicity; Prospective study; Testicular cancer patients

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FATIGUE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NEUROTOXICITY; ORCHIECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TESTIS CANCER;

EID: 79953871834     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq553     Document Type: Article

References (35)

1. Vardy J, Wefel JS, Ahles T et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19: 623-629.
2. Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007; 63: 183-202.
3. Jim HS, Donovan KA, Small BJ et al. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 2009; 115: 1776-1783.
4. Mehlsen M, Pedersen AD, Jensen AB, Zachariae R. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 2008; 18: 248-257.
5. Hermelink K, Untch M, Lux MP et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007; 109: 1905-1913.
6. Jenkins V, Shilling V, Deutsch G et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006; 94: 828-834.
7. Stewart A, Collins B, Mackenzie J et al. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 2008; 17: 122-130.
8. Debess J, Riis JO, Engebjerg MC, Ewertz M. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 2010; 121: 91-100.
9. Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007; 25: 2455-2463.
10. Schagen SB, Boogerd W, Muller MJ et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008; 47: 63-70.
11. Pedersen AD, Rossen P, Mehlsen MY et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 2009; 15: 296-301.
12. Peckham M. Testicular cancer. Acta Oncol 1988; 27: 439-453.
13. Brandt J, Benedict R. Hopkins Verbal Learning Test-Revised. Professional Manual. Lutz, FL: Psychological Assessment Resources Inc 2001.
14. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Theory and Clinical Interpretation, 2nd edition. Tucson, AZ: Neuropsychology Press 1993.
15. Delis DC, Kaplan E, Kramer JH, Ober BA. California Verbal Learning Test-Second Edition (CVLT II). Manual. San Antonio, TX: Psychological Corporation 2000.
16. Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996; 11: 329-338.
17. Sahakian BJ, Owen AM. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992; 85: 399-402.
18. Levaux MN, Potvin S, Sepehry AA et al. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry 2007; 22: 104-115.
19. Cambridge Cognition. CANTAB Eclipse Test Administration Guide. Cambridge, UK: Cambridge Cognition Limited 2005.
20. Nelson HE, Willison JR. The National Adult Reading Test-Test Manual, 2nd edition. Windsor: NFER-Nelson 1991.
21. Vaskinn A, Sundet K. Estimation of premorbid IQ: a Norwegian version of the National Adult Reading Test [Article in Norwegian]. Tidsskr Nor Psykologiforen 2001; 38: 1133-1140.
22. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale-measure of subjective stress. Psychosom Med 1979; 41: 209-218.
23. Tuinman MA, Hoekstra HJ, Sleijfer DT et al. Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy. Support Care Cancer 2007; 15: 279-286.
24. Chalder T, Berelowitz G, Pawlikowska T et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-153.
25. Oldenburg J, Fossa SD, Dahl AA. Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 2006; 15: 791-800.
26. Eysenck HJ, Eysenck SBG. Manual of the EPQ. London: Hodder and Stoughton 1975.
27. Eysenck SBG, Tambs K. Cross-cultural comparison of personality: Norway and England. Scand J Psychol 1990; 31: 191-197.
28. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905-1907.
29. McSweeny AJ, Naugle RI, Chelune GJ, Luders H. 'T Scores for change': an illustration of a regression approach to depicting change in clinical neuropsychology. Clin Neuropsychol 1993; 7: 300-312.
30. Ouimet LA, Stewart A, Collins B et al. Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J Clin Exp Neuropsychol 2009; 31: 73-89.
31. Fossa SD, Oldenburg J, Dahl AA. Short-and long-term morbidity after treatment for testicular cancer. BJU Int 2009; 104: 1418-1422.
32. Troy L, McFarland K, Littman-Power S et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 2000; 9: 29-39.
33. Skaali T, Fossa SD, Anderssson S et al. Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance? Psychooncology 2010 [Epub ahead of print]. doi: 10.1002/pon.1737.
34. Eberhard J, Stahl O, Cwikiel M et al. Risk factors for post-treatment hypogonadism in testicular cancer patients. Eur J Endocrinol 2008; 158: 561-570.
35. Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 2006; 155: 773-781.